# MDI Health Technologies

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/mdi-health-technologies

- Industry: Healthcare IT
- Headquarters: Israel
- Website: www.mdihealth.com
- Total disclosed funding: $26M
- Latest round: Series A (Feb 14, 2023)
- Investors on record: 8

## About

MDI Health Technologies Ltd., based in Israel, is a healthcare technology firm specializing in personalized AI medication management solutions aimed at optimizing patient outcomes and minimizing medication-related issues.Founded in 2019 by Avishai Ben-Tovim, Dorit Nahlieli, and Yuval Kalev, MDI Health Technologies Ltd. focuses on developing advanced medication management platforms. The company is headquartered in Tel Aviv, Israel, and has executed 2 deals to date. Most recently, on February 14, 2023, the company raised USD 20.00 mn in Series A funding led by Intel Capital, with participation from other investors such as Arc Impact and Fresh.fund.MDI Health Technologies offers a personalized AI medication management platform designed to significantly reduce prescription and medical costs while preventing medication-related problems. The platform employs advanced data analytics and artificial intelligence to identify high-risk patients, autonomously generate actionable clinical recommendations, and continuously monitor changes in health and medication treatment. Key functionalities include hyper-personalized analysis of patients' medication risks, automated suggestions for addressing those risks, and comprehensive data collection to view patients holistically. The company primarily serves health plans, value-based providers, health systems, and pharmacies, with a focus on the U.S. healthcare market.MDI Health Technologies generates revenue through its subscription-based model, catering primarily to B2B clients such as health plans and value-based providers. Clients typically engage in long-term partnerships that involve annual licenses for the use of the medication management platform. The firm offers various service levels based on the specific needs of the client, which could include comprehensive medication reviews and ongoing patient monitoring. The pricing structure is designed to deliver significant cost savings for high-risk populations, potentially saving up to USD 2,000 per patient per year.In February 2023, MDI Health Technologies Ltd. raised USD 20.00 mn in Series A funding, which will be utilized to expand its workforce in the U.S. and Israel. The company aims to enhance its existing medication management platform and plans to explore new markets, specifically targeting expansion into additional U.S. healthcare regions by the end of 2024.

## Funding rounds

- Series A, Feb 14, 2023, $20M — Intel Capital, Maverick Ventures Israel, JumpSpeed Ventures, Hanaco Venture Capital, Fresh.fund, Arc Impact, Welltech Ventures, Based Ventures
- Seed, Jun 29, 2021, $6M — JumpSpeed Ventures, Hanaco Venture Capital, Fresh.fund, Arc Impact, Based Ventures

## Investors

- JumpSpeed Ventures (https://capitalatlas.ai/funds/jumpspeed-ventures) — Seed, Series A
- Hanaco Venture Capital (https://capitalatlas.ai/funds/hanaco-venture-capital) — Seed, Series A
- Fresh.fund (https://capitalatlas.ai/funds/fresh-fund) — Seed, Series A
- Arc Impact (https://capitalatlas.ai/funds/arc-impact) — Seed, Series A
- Based Ventures (https://capitalatlas.ai/funds/based-ventures) — Seed, Series A
- Intel Capital (https://capitalatlas.ai/funds/intel-capital) — Series A
- Maverick Ventures Israel (https://capitalatlas.ai/funds/maverick-ventures-israel) — Series A
- Welltech Ventures (https://capitalatlas.ai/funds/welltech-ventures) — Series A